Understanding Charcot-Marie-Tooth (CMT) Disease: Causes, Symptoms, and Treatments
What is Charcot-Marie-Tooth (CMT) Disease?
Charcot-Marie-Tooth (CMT) disease is a hereditary neurological disorder that affects the peripheral nerves, responsible for transmitting signals between the brain, spinal cord, and muscles. CMT, also known as hereditary motor and sensory neuropathy, is one of the most common inherited neurological disorders, affecting an estimated 126,000 individuals in the United States and 2.6 million people worldwide [1]. CMT compromises patient lifestyles, everyday activities, and career and family choices. [2]. The disease is progressive, leading to muscle weakness and atrophy, particularly in the feet, legs, hands, and arms, and can significantly impact a person’s quality of life.
Types of Charcot-Marie-Tooth Disease
CMT is classified into several types based on the genetic mutations involved and the specific nerves affected:
-
CMT1: The most common form, CMT1, is caused by mutations in genes affecting the myelin sheath, the protective covering of nerve fibers [3]. This type leads to muscle weakness and sensory loss, especially in the legs and feet. CMT1 accounts for about 70-80% of all CMT cases [4].
-
CMT2: CMT2 involves damage to the nerve axons rather than the myelin sheath [5]. This type typically presents later in life and can cause significant muscle weakness and atrophy.
-
CMTX: Linked to the X chromosome, CMTX can affect both males and females, though males often experience more severe symptoms. It can cause symptoms similar to both CMT1 and CMT2 [6].
Causes of Charcot-Marie-Tooth Disease
CMT is caused by genetic mutations that affect the structure and function of peripheral nerves. The disease is primarily inherited in an autosomal dominant manner, meaning only one copy of the mutated gene from one parent is required to develop the disease [3]. About 90% of people with CMT inherit it from a parent with the condition, while the remaining cases are due to spontaneous mutations [7].
Symptoms of Charcot-Marie-Tooth Disease
Symptoms of CMT vary depending on the type and severity but generally include:
- Muscle weakness, especially in the lower legs and feet [9]
- Toe-walking and frequent tripping
- Difficulty walking, running, or maintaining balance [10]
- Frequent ankle rolls or sprains
- High foot arches or flat feet [11]
- Frequent kneecap dislocations
- Foot drop (difficulty lifting the front part of the foot) [12]
- Numbness or tingling in the hands and feet [13]
- Muscle cramps and decreased muscle mass [14]
- Difficulty with using writing or eating utensils, zippers, buttons, keys (problems with tasks involving fine motor skills)
- Fatigue
- Chronic pain in areas affected (pain can be neuropathic or musculoskeletal)
Statistics on Charcot-Marie-Tooth Disease
- Prevalence: CMT is one of the most common inherited neurological disorders, affecting an estimated 126,000 individuals in the United States and 2.6 million people worldwide [1]. Charcot-Marie-Tooth disease (CMT) affects 1 in 2,500 people and is caused by mutations in more than 30 genes [15].
- Types of CMT: The most common form, CMT1, accounts for 70-80% of all cases. CMT2 and CMTX are less common but still significantly impact those affected [4].
- Inheritance: About 90% of individuals with CMT inherit it from a parent, with the remaining 10% resulting from spontaneous genetic mutations [7]. Though there are a myriad of gene associations and mechanisms, four genes comprise over 90% of genetically confirmed cases of CMT [8].
Diagnosis & Testing
Diagnosing CMT involves a combination of clinical evaluation and diagnostic testing. Testing is crucial to confirm the presence of CMT, determine the specific type, and guide treatment decisions. The following are common testing methods for CMT:
Genetic Testing: Genetic testing is the most definitive method for diagnosing CMT. It involves analyzing a blood sample to identify mutations in the genes associated with CMT. This test can confirm the diagnosis, determine the specific type of CMT, and provide information about the inheritance pattern [15].
Nerve Conduction Studies (NCS): NCS measures the speed and strength of electrical signals as they travel through the peripheral nerves. In CMT, these signals are often slower or weaker due to nerve damage, helping to confirm the diagnosis and assess the severity of the disease [16].
Electromyography (EMG): EMG is a test that evaluates the electrical activity of muscles. By inserting a needle electrode into the muscle, doctors can assess the response of the muscle to nerve signals. Abnormal results can indicate nerve damage consistent with CMT [16].
Nerve Biopsy: In rare cases, a small sample of nerve tissue may be taken and examined under a microscope. This test can provide detailed information about the type of nerve damage and help differentiate CMT from other conditions with similar symptoms [16].
Treatment for Charcot-Marie-Tooth Disease
While there is no cure for CMT, treatment focuses on managing symptoms and maintaining mobility:
- Physical Therapy: Exercises and stretches help maintain muscle strength and flexibility [2].
- Orthopedic Devices: Braces, splints, and custom footwear can support weak muscles and improve mobility [16].
- Pain Management: Medications and other therapies can help manage pain and discomfort associated with CMT [16].
- Surgery: In severe cases, surgery may be necessary to correct foot deformities or other orthopedic issues [16].
- Controlled Clinical Trial Participation: For the first time, new disease-modifying treatments are being studied within controlled clinical trials. Early diagnosis of CMT Disease remains important as the first step for participation. To learn more about participating in clinical trials for CMT Disease, click here.
Living with Charcot-Marie-Tooth (CMT) Disease
Living with CMT can be challenging, but with appropriate care and support, individuals can lead fulfilling lives. It is important to work closely with healthcare providers to develop a personalized care plan tailored to individual needs.
Kane Hall Barry Neurology is committed to providing comprehensive care for patients with Charcot-Marie-Tooth disease. Our practice has been recognized as a Center of Excellence for Charcot-Marie-Tooth Disease by the Charcot-Marie-Tooth Association (CMTA) and serves as the only practice certified to treat CMT Disease in adults in the Dallas-Fort Worth Metroplex.
Our clinic offers a wide range of diagnostic and treatment options tailored to each patient’s unique situation. To learn more about our services or to schedule an appointment, please call our office at (817) 267-6290 or schedule a new patient appointment online.
Proudly Recognized by
References
National Institute of Neurological Disorders and Stroke. Charcot-Marie-Tooth Disease. National Institutes of Health. Accessed September 16, 2024. https://catalog.ninds.nih.gov/sites/default/files/publications/charcot-marie-tooth-disease.pdf
Thomas FP, Saporta MA, Attarian S, et al. Patient-Reported Symptom Burden of Charcot-Marie-Tooth Disease Type 1A: Findings From an Observational Digital Lifestyle Study. J Clin Neuromuscul Dis. 2022;24(1):7-17. doi:10.1097/CND.0000000000000426. Epub 2022 Aug 19. PMID: 36005469; PMCID: PMC9394494. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394494/
Nagappa M, Sharma S, Taly AB. Charcot-Marie-Tooth Disease. [Updated June 22, 2024]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562163/
Muscular Dystrophy Association. Charcot-Marie-Tooth Disease Types: CMT1. Accessed September 16, 2024. https://www.mda.org/disease/charcot-marie-tooth/types/cmt1
Fridman V, Saporta MA. Mechanisms and Treatments in Demyelinating CMT. Neurotherapeutics. 2021;18(4):2236-2268. doi:10.1007/s13311-021-01145-z. Epub 2021 Nov 8. PMID: 34750751; PMCID: PMC8804145. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804145/
Charcot-Marie-Tooth Association. Genetics and Inheritance of Charcot-Marie-Tooth Disease. Accessed September 16, 2024. https://www.cmtausa.org/understanding-cmt/diagnosing-cmt/genetics-and-inheritance/
Rudnik-Schöneborn S, Auer-Grumbach M, Senderek J. Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathies – Update 2020. Medizinische Genetik. 2020;32(3):207-219. doi:10.1515/medgen-2020-2038. https://www.degruyter.com/document/doi/10.1515/medgen-2020-2038/html?lang=en
Morena J, Gupta A, Hoyle JC. Charcot-Marie-Tooth: From Molecules to Therapy. Int J Mol Sci. 2019;20(14):3419. doi:10.3390/ijms20143419. PMID: 31336816; PMCID: PMC6679156. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679156/
National Health Service. Charcot-Marie-Tooth Disease Symptoms. Accessed September 16, 2024. https://www.nhs.uk/conditions/charcot-marie-tooth-disease/symptoms/
Nonnekes J, Hofstad C, de Greef-Rotteveel A, et al. Management of Gait Impairments in People with Charcot-Marie-Tooth Disease: A Treatment Algorithm. J Rehabil Med. 2021;53(5). doi:10.2340/16501977-2831. PMID: 33880570; PMCID: PMC8814859. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814859/
American Academy of Orthopaedic Surgeons. Charcot-Marie-Tooth Disease. Accessed September 16, 2024. https://orthoinfo.aaos.org/en/diseases–conditions/charcot-marie-tooth-disease
National Institute of Neurological Disorders and Stroke. Foot Drop Syndrome. Accessed September 16, 2024. https://www.ninds.nih.gov/health-information/disorders/foot-drop-syndrome
Johnson NE, Sowden J, Dilek N, et al. Prospective Study of Muscle Cramps in Charcot-Marie-Tooth Disease. Muscle Nerve. 2015;51(4):485-488. doi:10.1002/mus.24333. Epub 2015 Feb 11. PMID: 25042364; PMCID: PMC4860275. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860275/
Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies. Ann Neurol. 2011;69(1):22-33. doi:10.1002/ana.22166. PMID: 21280073; PMCID: PMC3058597. https://pubmed.ncbi.nlm.nih.gov/21280073/
National Institute of Neurological Disorders and Stroke. Peripheral Neuropathy. National Institutes of Health. Updated April 18, 2023. Accessed September 16, 2024. https://www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy
Reviewed for accuracy by: Sharique Ansari, MD, MPH, Director of the Charcot-Marie-Tooth Center of Excellence at Kane Hall Barry Neurology. Dr. Ansari is the only physician certified by the CMTA to treat CMT Disease in adults within the D/FW Metroplex. Dr. Ansari received training from Michael Shy, MD, a world-renowned CMT physician.